The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Moderna reported Q2 2026 revenue of $0.1 billion and a net loss of $0.8 billion. The company improved its 2026 operating expense outlook by $0.2 billion and is awaiting an August 5 PDUFA date for its influenza vaccine. Separately, AutoNation reported Q2 revenue of $6.9 billion and an adjusted EPS of $5.56.